Medical technology company Stryker (NYSE:SYK) reported in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its ...

Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

What Happened: Pierce, Group President at Stryker, made a strategic move by exercising stock options for 9,455 shares of SYK as detailed in a Form 4 filing on Thursday with the U.S. Securities and ...

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Looking ahead, revenue ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

In a report released today, Michael Matson from Needham reiterated a Buy rating on Stryker (SYK – Research Report), with a price target of ...